4//SEC Filing
MCDONOUGH GEOFF 4
Accession 0001415889-25-001414
CIK 0001733294other
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 4:05 PM ET
Size
8.7 KB
Accession
0001415889-25-001414
Insider Transaction Report
Form 4
MCDONOUGH GEOFF
Director
Transactions
- Award
Stock Option (right to buy)
2025-01-10+901,690→ 901,690 totalExercise: $0.93Exp: 2035-01-09→ Common Stock (901,690 underlying)
Holdings
- 226,462(indirect: By Trust)
Common Stock
- 1,342,492
Common Stock
- 275,000(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]Includes 4,863 shares acquired under the company's employee stock purchase plan since October 15, 2024.
- [F2]The securities are directly held by the McDonough Family 2018 Irrevocable Trust, or the 2018 Trust. The reporting person is the settlor of the 2018 Trust, Allison L. McDonough and David S. Grayzel are trustees for the 2018 Trust, and the 2018 Trust is for the benefit of Graeme and Owen McDonough. The reporting person may be deemed to beneficially own the shares of common stock owned by the 2018 Trust.
- [F3]The securities are directly held by the McDonough Family 2020 Irrevocable Trust, or the 2020 Trust. The reporting person is the settlor of the 2020 Trust, Allison L. McDonough and David S. Grayzel are trustees for the 2020 Trust, and the 2020 Trust is for the benefit of Allison, Graeme and Owen McDonough. The reporting person may be deemed to beneficially own the shares of common stock owned by the 2020 Trust.
- [F4]The option to purchase 901,690 shares was granted on January 10, 2025. The shares underlying the option vest over four years, with 25% of the shares vesting on January 10, 2026 and the remaining shares vesting in equal quarterly installments thereafter.
Documents
Issuer
Generation Bio Co.
CIK 0001733294
Entity typeother
Related Parties
1- filerCIK 0001732701
Filing Metadata
- Form type
- 4
- Filed
- Jan 13, 7:00 PM ET
- Accepted
- Jan 14, 4:05 PM ET
- Size
- 8.7 KB